Study to Evaluate the Effectiveness of FluMist Vaccination in a School-Based Intervention Program
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Influenza
Related studies linked through entity extraction aliases.
Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold Adapted (CAIV-T) in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE3
A Phase II, Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine, CAIV-T in Healthy Children and Adolescents Ages 6 to Less Than 18 Years.
- Status
- COMPLETED
- Phase
- PHASE2
Trial to Assess Safety, Efficacy, Tolerability and Immunogenicity of Influenza Virus Vaccine, Liquid Formulation (CAIV-T), Administered Concomitantly With a Combination Live, Attenuated, Mumps, Measles, and Rubella Vaccine in Healthy Children Aged 11 - 24 Months
- Status
- COMPLETED
- Phase
- PHASE2
Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine(CAIV-T)in Healthy Adults Aged 18 to 59 and Healthy Adults Aged 60 Years and Older
- Status
- COMPLETED
- Phase
- PHASE2
Trial to Assess the Shedding,Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age
- Status
- COMPLETED
- Phase
- PHASE4
Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of Delivery Routes of Flu Vaccine in Adults
- Status
- COMPLETED
- Phase
- PHASE2
Young Adult Influenza Vaccine Immunogenicity Substudy
- Status
- COMPLETED
- Phase
- NA
Elderly Influenza Vaccine Immunogenicity Substudy
- Status
- COMPLETED
- Phase
- N/A
Trivalent rHA Dose Escalation Study in Elderly Subjects
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of the Safety and Immune Response of an Influenza Vaccine Made by a New Manufacturing Process With a Vaccine Made by the Traditional Manufacturing Process for Season 2003/2004
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Comparison of the Safety and Immune Response of Three Different Lots of an Influenza Vaccine Made by a New Manufacturing Process With a Vaccine Made by the Traditional Manufacturing Process for Season 2004/2005
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Comparison of One Versus Two Doses of Influenza Vaccine in Children 5-8 Years of Age
- Status
- COMPLETED
- Phase
- NA
Rapid Vaccination of Hard-To-Reach Populations
- Status
- UNKNOWN
- Phase
- NA
Electronic Health Records for Health Promotion
- Status
- COMPLETED
- Phase
- NA
T-cell Response-Flu Risk in Older Adults
- Status
- COMPLETED
- Phase
- NA
Comparison of Inactivated and Live, Attenuated Influenza Vaccine in Children 5-9 Years of Age-Year 3 Amendment
- Status
- COMPLETED
- Phase
- PHASE4
Control of Epidemic Influenza Through a School-based Influenza Vaccination Program
- Status
- COMPLETED
- Phase
- PHASE4
Influenza Immunity Against Pandemic Respiratory Virus
- Status
- COMPLETED
- Phase
- PHASE4